Zymedi is a cutting-edge brand driven by a bold vision of a disease-free world. With therapies designed to target even the most challenging diseases, Zymedi aims to revolutionize healthcare by offering more targets, choices, and hope. Operating on the belief that outsmarting diseases lies in transforming the role of aminoacyl-tRNA synthetases (ARSs), Zymedi focuses on pathways associated with angiogenesis, inflammation, tumorigenesis, and other critical processes in human diseases.

By restoring balance to the body through these pathways, Zymedi strives to pave the path from care to cure. What sets Zymedi apart are its core values, which serve as guiding principles. The brand prioritizes safety by directing its attention to ARS sites that minimize side effects.

Zymedi also distinguishes itself by being a pioneer in the field, as the only company systematically researching ARSs. Additionally, the brand takes pride in clearly demonstrating the working mechanisms of ARSs to the medical community. Lastly, Zymedi generates evidence to exhibit the disease-specific behaviors and activities of ARSs.

Zymedi's leadership team, well-versed in the biology of ARS, is committed to unlocking the full potential of ARS science. Their deep scientific knowledge has revealed that targeting ARSs can control diseases through multiple pathways, resulting in highly effective and broad-acting medicines. If you share Zymedi's passion for transforming drug discovery, the brand offers exciting career opportunities.

Zymedi also welcomes joint ventures, strategic investors, and in-licensing partners interested in identifying novel therapeutics for hard-to-treat disease areas. Join Zymedi today and be a part of their mission to create a healthier future